Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (21-30 of 372) with videos related to

Pageof 38
Sort By:
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver diseaseElisabetta Degasperi, Massimo Colombo
Gastroenterology|September 24, 2013
Nucleos(t)ide analogs-based chemoprevention of liver cancer in hepatitis B patients: effective, yet in search of optimizationPietro Lampertico, Massimo Colombo
Hepatobiliary Surgery and Nutrition|November 21, 2017
Expanding transplantation of patients with a liver cancer without harming allocation: a priority in the era of scarce donationMassimo Colombo, Guido Torzilli
Translational Gastroenterology and Hepatology|February 1, 2019
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the differenceMassimo Colombo, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Treatment of hepatocellular carcinoma: beyond international guidelinesAngelo Sangiovanni, Massimo Colombo
Seminars in Liver Disease|November 5, 2014
Hepatocellular carcinoma screening and diagnosisMorris Sherman, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Treatment of hepatocellular carcinoma: beyond international guidelinesMassimo Colombo, Angelo Sangiovanni
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
How I manage my patients with hepatocellular carcinomaMassimo Colombo, Angelo Sangiovanni
Gastroenterology|January 28, 2009
Cirrhosis regression in chronic hepatitis C: an old tale with a new endingAlessio Aghemo, Massimo Colombo
Gastroenterology|February 7, 2018
Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?Alessio Aghemo, Massimo Colombo
Pageof 38

Showing results (21-30 of 372) with videos related to

Sort By:
Pageof 38
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver diseaseElisabetta Degasperi, Massimo Colombo
Gastroenterology|September 24, 2013
Nucleos(t)ide analogs-based chemoprevention of liver cancer in hepatitis B patients: effective, yet in search of optimizationPietro Lampertico, Massimo Colombo
Hepatobiliary Surgery and Nutrition|November 21, 2017
Expanding transplantation of patients with a liver cancer without harming allocation: a priority in the era of scarce donationMassimo Colombo, Guido Torzilli
Translational Gastroenterology and Hepatology|February 1, 2019
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the differenceMassimo Colombo, Ana Lleo
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Treatment of hepatocellular carcinoma: beyond international guidelinesAngelo Sangiovanni, Massimo Colombo
Seminars in Liver Disease|November 5, 2014
Hepatocellular carcinoma screening and diagnosisMorris Sherman, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Treatment of hepatocellular carcinoma: beyond international guidelinesMassimo Colombo, Angelo Sangiovanni
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
How I manage my patients with hepatocellular carcinomaMassimo Colombo, Angelo Sangiovanni
Gastroenterology|January 28, 2009
Cirrhosis regression in chronic hepatitis C: an old tale with a new endingAlessio Aghemo, Massimo Colombo
Gastroenterology|February 7, 2018
Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?Alessio Aghemo, Massimo Colombo
Pageof 38